Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment

Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment

BackgroundTo investigate risk factors for coronary arterial abnormalities (CAAs) and resistance to treatment in patients with Kawasaki disease (KD) receiving intravenous immunoglobulin (IVIG) plus ciclosporin A (CsA) as the first-line treatment, we performed a subanalysis of baseline data of partici...

Full description

Bibliographic Details
Main Authors: Yuri Murayama, Hiromichi Hamada, Yuki Shiko, Yoshihiro Onouchi, Nobuyuki Kakimoto, Yoshihito Ozawa, Hideki Hanaoka, Akira Hata, Hiroyuki Suzuki
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Pediatrics
Subjects:
Kawasaki disease
coronary artery disease
immunoglobulin
ciclosporin A
subanalysis
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1321533/full

Similar Items

Similar Items